# Generate Biomedicines, Inc.: Form 8-K, filed Mar 2, 2026

- Company: [Generate Biomedicines, Inc.](/companies/genb.md) (CIK 2100782)
- Form: 8-K
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 17:22 ET
- Period: 2026-02-26
- Accession: 0001193125-26-085780
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/ck0002100782-20260226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/ck0002100782-20260226.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-085780. Last ingested by Listed: Nov 12, 2026, 17:50 ET. No prices; not investment advice.
